9:15 AM
Oct 04, 2018
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Colorectal cancer; breast cancer; ovarian cancer

Cell culture and mouse studies suggest niclosamide could help treat p53-mutant colorectal, ovarian and breast cancers. High throughput screening of a library of 1,600 approved compounds in p53-wild type and p53-knockout...

Read the full 161 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >